Locally Advance Breast Cancer (LABC)
1 clinical trials · Condition
◉ Watch Locally Advance Breast Cancer (LABC)
| Record | Firm | Date |
|---|---|---|
| A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab (NCT01471847) | Novartis Pharmaceuticals | 2012-02-01 |
Track Locally Advance Breast Cancer (LABC) automatically
Every clearance here is in the API, with alerts when new ones post.